5-methylurapidil has been researched along with Hypertrophy, Left Ventricular in 1 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, A | 1 |
| Sattar, MA | 1 |
| Azam, M | 1 |
| Abdulla, MH | 1 |
| Khan, SA | 1 |
| Hashmi, F | 1 |
| Abdullah, NA | 1 |
| Johns, EJ | 1 |
1 other study available for 5-methylurapidil and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Cystathione gamma lyase/Hydrogen Sulphide Pathway Up Regulation Enhances the Responsiveness of α1A and α1B-Adrenoreceptors in the Kidney of Rats with Left Ventricular Hypertrophy.
Topics: Adrenergic beta-Antagonists; Animals; Clonidine; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypert | 2016 |